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INTRODUCTION
The blood-brain barrier (BBB) is a multicellular vascular 
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Objective: Whether blood-brain barrier (BBB) disruption induced by chronic spontaneous hypertension is associated with 
beta-amyloid (Aβ) accumulation in the brain remains poorly understood. The purpose of this study was to investigate the 
relationship between BBB disruption and Aβ influx and accumulation in the brain of aged rats with chronic spontaneous 
hypertension. 
Materials and Methods: Five aged spontaneously hypertensive rats (SHRs) and five age-matched normotensive Wistar-
Kyoto (WKY) rats were studied. The volume transfer constant (Ktrans) obtained from dynamic contrast-enhanced magnetic 
resonance imaging (DCE-MRI) was used to evaluate BBB permeability in the hippocampus and cortex in vivo. The BBB tight 
junctions, immunoglobulin G (IgG), Aβ, and amyloid precursor protein (APP) in the hippocampus and cortex were examined 
with immunohistochemistry. 
Results: As compared with WKY rats, the Ktrans values in the hippocampus and cortex of the SHRs increased remarkably (0.316 
± 0.027 min-1 vs. 0.084 ± 0.017 min-1, p < 0.001 for hippocampus; 0.302 ± 0.072 min-1 vs. 0.052 ± 0.047 min-1, p < 0.001 
for cortex). Dramatic occludin and zonula occludens-1 losses were detected in the hippocampus and cortex of SHRs, and 
obvious IgG exudation was found there. Dramatic Aβ accumulation was found and limited to the area surrounding the BBB, 
without extension to other parenchyma regions in the hippocampus and cortex of aged SHRs. Alternatively, differences in 
APP expression in the hippocampus and cortex were not significant.
Conclusion: Blood-brain barrier disruption is associated with Aβ influx and accumulation in the brain of aged rats with 
chronic spontaneous hypertension. DCE-MRI can be used as an effective method to investigated BBB damage. 
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structure made up of endothelium, pericytes, and astrocytes 
that separates the central nervous system from the 
peripheral blood circulation (1). It inhibits the transfer 
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contrast-enhanced magnetic resonance imaging (DCE-MRI) 
(19-22). In addition, we sought to evaluate the presence of 
the BBB tight junction proteins (i.e., occludin and ZO-1), 
immunoglobulin G (IgG), Aβ, and APP in the hippocampus 
and cortex with immunohistochemistry. 
MATERIALS AND METHODS
Animals
Male SHRs that were 17 months old (male, n = 5) and 
age-matched male Wistar-Kyoto (WKY) rats (n = 5) were 
purchased from Dashuo Laboratory Animal Co., Ltd., 
Chengdu, China. The rats were housed in the Animal 
Resources Center at West China Hospital, Sichuan University, 
and they had free access to food and water. They were kept 
in conditions that mimicked normal daily light and dark 
cycles. All of the experimental procedures were approved by 
the local animal committee of West China Hospital, Sichuan 
University, Chengdu, China.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging 
Methods and Data Analysis 
All the MRI experiments were performed using a 7T MR 
scanner (Bruker BioSpec 70/30; Bruker Biospin Ettlingen, 
Germany). Rats were anesthetized with a 2% isoflurane/
oxygen mixture throughout the MRI examinations. The 
rats’ body temperatures were kept constant at 37°C using 
a heating blanket and monitored with a rectal temperature 
probe. 
All the rats underwent T2-weighted imaging using a 
T2 spin-echo sequence (repetition time/echo time = 
4000/33 ms). The field of view was 35 × 35 mm, number 
of excitation was 2, and the matrix was 256 × 256 mm. 
Twenty-five 1.0-mm-thick coronal slices were acquired from 
each animal. DCE-MRI and data analysis were performed 
as previously described (21). A bolus of contrast agent 
(Magnevist [gadopentetate dimeglumine], 0.2 mmol/kg, 10 
seconds duration; BeiLu Pharmaceutical Co., Ltd., Beijing, 
China) was manually injected through each rat’s caudal 
vein after 10 precontrast images were acquired. A series of 
120 dynamic T1 spin-echo images were acquired, with the 
following parameters: repetition time/echo time, 200/10.5 
ms; field of view, 30 x 30 mm; number of excitation, 3; flip 
angle, 178.5 degrees; slice thickness, 2 mm; and in-plane 
resolution, 234 x 234 μm/pixel. 
The Ktrans value was calculated with the use of DCE@urLAB 
1.0 software for Microsoft Windows 7 (Microsoft, Redmond, 
of substances from the blood to the brain and vice versa 
and thus maintains an environment that allows neurons to 
function correctly. Some of the main structures responsible 
for the properties of the BBB are the tight junctions (TJs), 
such as occluding (2). The TJs and their adaptor molecules 
(e.g., zonula occludens-1 [ZO-1]), which link the TJs to the 
cytoskeleton of endothelial cells and which are essential 
for the stability and function of the BBB (3), are often 
affected in the presence of acute and chronic diseases of 
the brain (4). If one part of the barrier malfunctions, the 
BBB is disrupted, and this may lead to extravasation and 
further devastating consequences, such as neuronal damage. 
Previous studies have found that BBB leakage in the brain 
can be induced by spontaneous hypertension (5, 6). 
The production of beta-amyloid (Aβ)−an Alzheimer’s 
disease biomarker−results from the amyloidogenic processing 
of the amyloid precursor protein (APP) (7, 8), which is 
a ubiquitously expressed transmembrane glycoprotein 
(9, 10). Physiologically, Aβ is released continuously in 
soluble globular form as a product of whole body cellular 
metabolism, and it circulates in the bloodstream (11). 
The Aβ generated in the brain can be eliminated from the 
brain by the BBB through receptor-mediated transport and 
perivascular drainage via the vascular basement membrane 
(12, 13). Plasma-derived Aβ can also be transferred into 
the brain through a specific receptor or carrier-mediated 
mechanisms. The transport of Aβ across the BBB largely 
determines the concentration of Aβ in the brain (14). 
Therefore, BBB dysfunction may lead to Aβ accumulation 
in the brain. Previous studies have demonstrated that 
hypertension is one of the most common cardiovascular 
risk factors for Alzheimer’s disease (15, 16). The possible 
mechanism for this may be that hypertension induces Aβ 
accumulation in the brain via the following routes: 1) 
increasing APP expression (17); 2) enhancing APP cleavage 
(18); 3) enhancing receptor-based Aβ influx processing (15); 
and 4) impairing Aβ clearance (17). However, the exact 
mechanism is still unclear, and it is unknown whether Aβ 
can pass through the disrupted BBB to deposit itself in the 
brain of an individual with hypertension. We hypothesize 
that BBB disruption is associated with Aβ influx and 
accumulation in the brain of aged rats with chronic 
spontaneous hypertension. 
In the present study, we intended to investigate BBB 
permeability changes in the hippocampus and cortex of 
aged spontaneously hypertensive rats (SHRs) in vivo using 
volume transfer constant (Ktrans) obtained from dynamic 
500
Wang et al.
Korean J Radiol 19(3), May/Jun 2018 kjronline.org
WA, USA; http://www.die.upm.es/im/archives/DCEurLAB/). 
All data processing was performed as previously described 
(21). The data analysis was performed by two independent 
observers, who had five-year experience in MRI diagnosis 
and were blinded to each animal’s status. Four regions of 
interest (ROIs) of the right hippocampus (ROI 1 and 3) and 
the cortex (ROI 2 and 4) were manually drawn on slice 1 
(bregma, -3.60 mm) and slice 2 (bregma, -5.60 mm) of each 
animal in accordance with the standard rat brain atlas (23), 
as shown in Figure 1. Both the right and left hippocampus 
and the cortex were analyzed, and the ROIs of the left 
hippocampus and the cortex were manually drawn as the 
ROIs of the right hippocampus and the cortex. Twenty total 
slices were included for the Ktrans value analysis. For each 
rat, the Ktrans value of the complete hippocampus or cortex 
was calculated as the average of the Ktrans values of four 
ROIs of two slices. We chose the extended Tofts model to 
calculate the Ktrans value because this model includes the 
parameter of the plasma volume (24).
 
Immunohistochemistry 
The brain sections were harvested, fixed in 4% 
formaldehyde, and embedded in paraffin. The sections 
that contained the hippocampus and cortex in bregma 
-3.60 mm was cut into 5-μm-thick slices with a sliding 
microtome (CM 3000; Leica, Bensheim, Germany). Double-
labeling immunostaining was performed for occludin and 
glial fibrillary acidic protein (GFAP), ZO-1 and GFAP, IgG 
and GFAP, and Aβ and GFAP, respectively. Single-labeling 
immunostaining was performed for APP. Details of the 
primary antibodies used are given in Table 1, and details of 
the immunostaining method have been described previously 
(25). The slides were incubated with blocking solution (5% 
normal goat serum in 0.1 M phosphate-buffered saline) for 
1 hour at room temperature and then incubated overnight 
at 4°C with the primary antibodies. The sections were 
then incubated with secondary antibodies for 1 hour at 
room temperature. The secondary antibodies used in this 
experiment were Alexa Fluor 488 goat anti-chicken IgY 
H&L (1:200; Abcam), Alexa Fluor 594 goat anti-chicken IgY 
H&L (1:200; Abcam), and DyLight 594 goat anti-rabbit IgG 
H&L (1:200; Abcam). The nuclei were counterstained with 
4’,6-diamidino-2-phenylindole. The images were acquired 
via a Leica AF6000 cell station (Leica, Solms, Germany). 
IgG, Aβ, and APP in the right hippocampus and cortex were 
evaluated by measuring selectively green or red fluorescence 
intensity, which was corrected for background fluorescence 
and expressed as arbitrary fluorescence units (FAU) (26). 
All images were taken during the first 30 seconds of light 
exposure when no fluorescence decay was detected in 
preliminary studies. The data analysis was performed by two 
experienced laboratory technicians, who were blinded to 
each animal’s status. 
Statistical Analysis 
Statistical analysis was performed with the use of SPSS 
for Windows, Version 20 (IBM Corp., Armonk, NY, USA). 
Quantitative data were tested for normal distribution by 
Fig. 1. ROI definition in right hippocampus and cortex of rats. Hippocampus was defined at bregma -3.60 mm (ROI 1) and bregma -5.60 
mm (ROI 3) on coronal T2WI. Cortex was defined at bregma -3.60 mm (ROI 2) and bregma -5.60 mm (ROI 4) on coronal T2WI. R = right, ROI = 
region of interest, T2WI = T2-weighted imaging
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using the Kolmogorov-Smirnov test. Normally distributed 
data were expressed as a mean ± standard deviation. 
Two-tailed independent-sample t tests were used for 
animal age, body weight, blood pressure, Ktrans value, and 
histological data comparison between the two groups. P < 
0.05 indicated a significant difference in all the statistical 
procedures. 
RESULTS
Characteristics of Aged Spontaneously Hypertensive Rats 
and Age-Matched Wistar-Kyoto Rats 
The attributes of aged SHRs and age-matched WKY rats 
are displayed in Table 2. As compared with age-matched 
WKY rats, aged SHRs had obviously higher levels of systolic 
blood pressure, diastolic blood pressure, and mean blood 
pressure. The body weights of the aged SHRs were lower 
than those of the age-matched WKY rats. 
Blood-Brain Barrier Permeability Increase in the 
Hippocampus and Cortex of Aged Spontaneously 
Hypertensive Rats 
Dynamic contrast-enhanced-MRI was used to evaluate 
BBB permeability in the hippocampus of aged SHRs and 
age-matched WKY rats in vivo. The Ktrans maps and the 
values of the right hippocampus and cortex of aged SHRs 
and age-matched WKY rats are shown in Figure 2. Low BBB 
permeability was detected in the right hippocampus and 
cortex of age-matched WKY rats (Fig. 2A, B, upper rows). By 
contrast, dramatically high BBB permeability was detected 
in the right hippocampus and cortex of aged SHRs (Fig. 2A, 
B, lower rows). The aged SHRs had significantly higher Ktrans 
values in the hippocampus (0.316 ± 0.027 min-1 vs. 0.084 
± 0.017 min-1, p < 0.001) and cortex (0.302 ± 0.072 min-1 
vs. 0.052 ± 0.047 min-1, p < 0.001) as compared with age-
matched WKY rats. 
Blood-Brain Barrier Disruption in the Hippocampus and 
Cortex of Aged Spontaneously Hypertensive Rats 
The primary structures responsible for the properties 
of the BBB are the TJs (e.g., occludin) (2). The adaptor 
molecules (e.g., ZO-1) that link the TJs to the cytoskeletons 
of the endothelial cells are essential for the stability and 
function of the BBB (3). Therefore, occludin and ZO-1 were 
used to detect the integrity of the BBB in the hippocampus 
and cortex. Astrocytes extend foot processes that encircle 
the abluminal side of the vessel almost completely (1). 
Thus, the astrocytic process around the blood vessel was 
also visualized by GFAP. In age-matched WKY rats, occludin 
immunoreactivity formed a continuous and sharply defined 
pattern of single or double lines marking the paracellular 
clefts of adjacent endothelial cells in the hippocampus and 
the cortex, as indicated by white asterisks in Figures 3A 
and 4A. However, in aged SHRs, occludin immunoreactivity 
in the BBB in the hippocampus and cortex disappeared, 
as indicated by white arrows in Figures 3A and 4A. The 
astrocytic process surrounding the blood vessels remained 
continuously immunoreactive to GFAP.
The pattern of ZO-1 immunoreactivity in the hippocampus 
and cortex of age-matched WKY rats was like that seen for 
Table 1. Overview of Primary Antibodies Used for Immunohistochemistry
Antibody Host Supplier Product No. Dilution Target
Occludin Rabbit Abcam ab31721 1/100 Tight junction protein
Zonula occludens-1 Rabbit Abcam ab59720 1/100 Tight junction protein
Glial fibrillary acidic protein Chicken Abcam ab4674 1/400 Astrocyte process
FITC-conjugated IgG Rabbit Abcam ab6730 1/200 IgG
Aβ1-42 Rabbit Bioss bs-0107R 1/100 Aβ1-42 peptide
APP Rabbit Abcam ab32136 1/400 APP
Aβ = beta-amyloid, APP = amyloid precursor protein, FITC = fluorescein isothiocyanate, IgG = immunoglobulin G
Table 2. Characteristics of Aged SHRs and WKY Rats
Parameters WKY Rats (n = 5) SHRs (n = 5) P
Age (months)   17.4 ± 0.3   17.6 ± 0.1 0.242
Body weight (g)   424.2 ± 30.9   280.2 ± 19.1 < 0.001
Systolic blood pressure (mm Hg)   140.6 ± 12.9   203.0 ± 10.1 < 0.001
Diastolic blood pressure (mm Hg)   94.2 ± 4.8 162.4 ± 7.7 < 0.001
Mean blood pressure (mm Hg) 109.7 ± 4.0 175.9 ± 5.0 < 0.001
Values are given as mean ± standard deviation. SHRs = spontaneously hypertensive rats, WKY = Wistar-Kyoto
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occludin expression and involved a continuous and sharply 
defined staining along the paracellular clefts, as indicated 
by white asterisks in Figures 3B and 4B. As described 
previously for occludin immunoreactivity, there were 
significant changes in ZO-1 expression in the hippocampus 
and cortex of aged SHRs. The continuous pattern of the 
paracellular expression of ZO-1 immunoreactivity in age-
matched WKY rats disappeared in aged SHRs, as indicated 
by white arrows in Figures 3B and 4B. 
Immunoglobulin Leakage and Beta-Amyloid 
Accumulation in the Hippocampus and Cortex of Aged 
Spontaneously Hypertensive Rats 
Blood-brain barrier disruption was indicated by the IgG 
positivity of the small vessel walls (17). GFAP was used 
to visualize the astrocyte process surrounding the blood 
vessels (1). The IgG immunoreactivity in the hippocampus 
and cortex of age-matched WKY rats was detected only 
within the cerebrovascular lumen, as indicated by black 
asterisks in Figure 5A. By contrast, aged SHRs showed 
dramatic IgG leakage and accumulation in the hippocampus 
and cortex (Fig. 5A). In addition, IgG immunoreactivity 
was particularly prevalent on the cerebral vessel walls and 
in the surrounding tissues, as indicated by white arrows in 
Figure 5A. The FAU values of Aβ in the hippocampus and 
cortex of aged SHRs were higher than those of age-matched 
WKY rats (36.644 ± 2.789 vs. 30.754 ± 1.183, p = 0.002 for 
hippocampus; 35.992 ± 2.230 vs. 30.583 ± 1.646, p 0.002 
for cortex), as shown in Figure 5C.
Aβ1-42 was used to detect the Aβ immunoreactivity in 
the hippocampus and cortex (7). The Aβ immunoreactivity 
in the hippocampus and cortex of age-matched WKY rats 
was detected only within the cerebrovascular lumen, as 
indicated by white asterisks in Figure 5B. By contrast, 
aged SHRs showed dramatic Aβ accumulation in the 
hippocampus and cortex (Fig. 5B). The Aβ immunoreactivity 
was particularly prevalent on the cerebral vessel walls and 
in the surrounding tissues, as indicated by white arrows in 
Figure 5B. The FAU values of Aβ in the hippocampus and 
cortex of aged SHRs were higher than those of age-matched 
WKY rats (26.355 ± 0.973 vs. 17.829 ± 2.116, p < 0.001 for 





Fig. 2. BBB permeability increase in hippocampus and cortex of aged SHRs. 
A. Hippocampus and cortex of aged SHRs and age-matched WKY rats at bregma -3.60 mm (slice 1). B. Hippocampus and cortex of aged SHRs and 
age-matched WKY rats at bregma -5.60 mm (slice 2). Left column shows hippocampus and cortex on T2WI. Middle column shows Ktrans maps of 
hippocampus. Right column shows Ktrans maps of cortex. Color-coded Ktrans values range between 0.0 min-1 and 3.0 min-1, with dark blue indicating 
0.0 min-1, green indicating 1.5 min-1, and red indicating 3.0 min-1. C. Ktrans values of right hippocampus of aged SHRs and age-matched WKY rats. 
D. Ktrans values of right cortex of aged SHRs and age-matched WKY rats. Values are expressed as mean ± standard deviation. BBB = blood-brain 
barrier, Ktrans = volume transfer constant, SHRs = spontaneously hypertensive rats, WKY = Wistar-Kyoto
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for cortex), as shown in Figure 5D. 
Amyloid Precursor Protein Expression in the 
Hippocampus and Cortex of Aged Spontaneously 
Hypertensive Rats and Age-Matched Wistar-Kyoto Rats 
Amyloid precursor protein expression in the hippocampus 
was evaluated with immunohistochemistry. No significant 
difference in APP expression in the hippocampus and cortex 
of aged SHRs and age-matched WKY rats was detected. 
Representative immunofluorescent images of the pyramidal 
layer in the cornu ammonis 1 subfield of the hippocampus 
and the cortex were shown in Figure 6A. The FAU values of 
APP in the hippocampus and cortex of aged SHRs were like 
those of age-matched WKY rats (43.603 ± 3.540 vs. 44.860 
± 0.725, p = 0.459 for hippocampus; 39.402 ± 1.869 vs. 
40.503 ± 0.931, p = 0.272 for cortex) (Fig. 6B). 
DISCUSSION
This study demonstrates for the first time that BBB 
disruption is associated with Aβ influx and accumulation 
in the brain of aged rats with chronic spontaneous 
hypertension. We found that Aβ accumulation was limited 
to the area surrounding the BBB without extension to other 
parenchyma regions in the brain of aged SHRs, whereas APP 
expression in the brain showed no significant results as 
compared with that of age-matched WKY rats. Our results 
suggest a bloodstream origin of brain Aβ accumulation 
(rather than a neuronal source) for those with chronic 
spontaneous hypertension. 
The disruption of the TJs in the brain because of 
spontaneous hypertension has been demonstrated 
previously (27). However, a study that evaluated the 
permeability of the BBB using a noninvasive method in 
subjects with hypertension was still missing. In the present 
study, we used the Ktrans values obtained from DCE-MRI 
to investigate BBB permeability changes in the brain of 
aged SHRs in vivo (19-21). The aged SHRs had dramatically 
higher Ktrans values in the hippocampus and cortex as 
compared with age-matched WKY rats, which indicated 
A B
Fig. 3. Occludin and ZO-1 decrease in hippocampus of aged SHRs.
A. Occludin (red) and GFAP (green) immunoreactivity in hippocampus of age-matched WKY rats (upper row) and aged SHRs (lower row). B. ZO-1 
(red) and GFAP (green) immunoreactivity in hippocampus of age-matched WKY rats (upper row) and aged SHRs (lower row). White asterisks 
indicate BBB surrounded by astrocyte processes. White arrows refer to decrease of occludin or ZO-1. Bar = 50 μm. GFAP = glial fibrillary acidic 










Fig. 4. Occludin and ZO-1 decrease in cortex of aged SHRs.
A. Occludin (red) and GFAP (green) immunoreactivity in cortex of age-matched WKY rats (upper row) and aged SHRs (lower row). B. ZO-1 (red) 
and GFAP (green) immunoreactivity in cortex of age-matched WKY rats (upper row) and aged SHRs (lower row). White asterisks indicate BBB 
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increased BBB permeability in these animals. With the 
use of immunohistochemistry, we found a dramatic loss 
of occludin and ZO-1 in the hippocampus and cortex of 
aged SHRs. These results were consistent with those of 
a previous study (27) and confirmed the BBB disruption 
in the hippocampus and cortex of aged SHRs that had 
been detected by DCE-MRI. Furthermore, dramatic IgG 
exudation and accumulation were also identified, which 
directly demonstrated BBB disruption in the hippocampus 
and cortex of aged SHRs. Thus, based on these findings, 
we propose that DCE-MRI can be used to perform a non-
invasive longitudinal assessment of an impaired BBB, which 






Fig. 5. IgG leakage and Aβ accumulation in hippocampus and cortex of aged SHRs.
A. IgG (green) and GFAP (red) immunoreactivity in hippocampus (upper row) and cortex (lower row) of aged SHRs and age-matched WKY 
rats. Black asterisks indicate cerebrovascular lumen surrounded by astrocyte processes. White arrows refer to IgG leakage and accumulation 
surrounding BBB. B. Aβ (red) and GFAP (green) immunoreactivity in hippocampus (upper row) and cortex (lower row) of aged SHRs and age-
matched WKY rats. White asterisks indicate cerebrovascular lumen surrounded by astrocyte processes. White arrows refer to Aβ accumulation 
surrounding BBB. Bar = 50 μm. C. FAU values of IgG in hippocampus and cortex of aged SHRs and age-matched WKY rats. D. FAU values of Aβ in 
hippocampus and cortex of aged SHRs and age-matched WKY rats. Values are expressed as mean ± standard deviation. Aβ = beta-amyloid, DAPI = 
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The Aβ generated in the brain can be eliminated from 
the brain by the BBB through receptor-mediated transport 
and perivascular drainage along the vascular basement 
membrane (12, 13). Plasma-derived Aβ can also be 
transferred into the brain through a specific receptor or 
carrier-mediated mechanisms. The transport of Aβ across 
the BBB largely determines the concentration of Aβ in 
the brain (14). Therefore, BBB dysfunction may lead to 
Aβ accumulation in the brain. In the present study, we 
found dramatic Aβ accumulation in the hippocampus and 
cortex of aged SHRs. The Aβ accumulation was limited to 
the area surrounding the BBB, without extension to other 
parenchyma regions, which suggest a bloodstream origin 
of brain Aβ accumulation (rather than a neuronal source) 
for those with chronic spontaneous hypertension. Aβ 
accumulation on microvessel walls with concomitant BBB 
leakage in the hippocampus and cortex has been found 
previously in subjects with chronic hypertension induced 
by transverse aortic coarctation or angiotensin II infusion 
(26); however, the integrity of the TJs in the BBB in the 
hippocampus was not investigated. More recently, it has 
been demonstrated that non-transgenic spontaneous 
hypertension caused visible Aβ accumulation with BBB 
leakage in the hippocampus of rats (17, 28). However, in 
those studies, Aβ was not limited to blood vessels, which 
indicated that the accumulated Aβ was not derived from 
plasma. Those studies also demonstrated that stroke-prone 
SHRs developed cerebral small vessel disease pathology, 
which may result in a failure to clear Aβ. These results 
were inconsistent with those of the present study, probably 
because of the differences in the hypertension model used 
and the duration of hypertension.
Amyloid precursor protein is an integral membrane protein 
that is abundantly expressed in the neuronal synapses 
(29). In patients with Alzheimer’s disease, its proteolysis 
generates Aβ, which is the main component of amyloid 
plaques. It has been reported that chronic hypertension 
could increase APP expression in the brain (17), and 
increased APP expression was found in 20-week-old stroke-
prone SHRs. Surprisingly, we did not find any significant 
differences in APP expression in the hippocampus and 
cortex of aged SHRs and age-matched WKY rats. This was in 
line with the study that demonstrated hypertension induced 
by the chronic infusion of angiotensin II into C57BL/6 mice 
failed to increase APP expression in the brain (29). Different 
models and durations of hypertension may help to explain 
this inconsistency. Overall, the unchanged APP expression-
together with the direct evidence of Aβ accumulation 
surrounding the BBB-indicated that Aβ accumulation in the 
hippocampus and cortex of aged SHRs was derived from 
plasma than from the brain. 
A further study with a larger number of subjects is 
warranted to confirm our findings in the future. In addition, 
there may have been other complications such as diabetes 
A B
Fig. 6. APP expression in hippocampus and cortex of aged SHRs and age-matched WKY rats.
A. APP immunoreactivity in hippocampus (upper row) and cortex (lower row) of aged SHRs and age-matched WKY rats. Bar = 50 μm. B. FAU 
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which we did not exclude but may have also led to BBB 
disruption.
In the present study, we found obvious BBB disruption 
with dramatic Aβ accumulation in the hippocampus and 
cortex of aged SHRs. The Aβ accumulation was limited 
to the area surrounding the BBB, without extension to 
other parenchyma regions. Alternatively, APP expression 
in the hippocampus and cortex was not significance as 
compared with that of WKY rats. Our results suggest a 
bloodstream origin of brain Aβ accumulation rather than a 
neuronal source. These results support that BBB disruption 
is associated with Aβ influx and accumulation in the 
hippocampus and cortex of aged SHRs. DCE-MRI can be 
used as an effective method to investigate BBB damage.
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